Research Article
Epidemiology and Outcomes in Critically Ill Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy
Table 4
Survival analysis for predictors of 30-day mortality.
| Variable | aHR (95% CI) | value |
| Age | 1.00 (0.96–1.03) | 0.75 | Male gender | 1.16 (0.62–2.16) | 0.64 | Cirrhosis | 2.30 (1.12–4.73) | 0.024 | CAD | 6.98 (2.20–22.13) | 0.001 | Men who have sex with men | 1.30 (0.54–3.11) | 0.55 | New diagnosis of HIV | 0.67 (0.20–2.26) | 0.52 | Duration of HIV (years) | 1.07 (1.02–1.13) | 0.010 | CD4 count (per 10 cells/mm3) | 1.00 (0.99–1.01) | 0.98 | HIV viral load (per 1000 copies/mL) | 1.00 (1.00–1.00) | 0.68 | APACHE II | 1.12 (1.08–1.16) | <0.001 | Admission diagnosis | | 0.46 | Shock | 0.80 (0.40–1.61) | 0.54 |
|
|